“The rating action reflects our view of Covenant’s sustained financial improvement coupled with stable balance sheet measures,” said S&P analyst Brian Williamson.
The outlook is stable, reflecting S&P’s view of Covenant’s strong balance sheet, dominant market share and solid operating results.
More articles on healthcare finance:
Fitch affirms Reading Hospital’s ‘A+’ rating
Moody’s affirms Excela Health’s ‘A3’ rating
Bronson Healthcare Group pays off $115M in series 2016 bonds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
